Drug Insights: Vitamin D and Its Analogs 2023
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (10 April 2024) | Viewed by 219
Special Issue Editor
2. International Research Centre "Biotechnologies of the Third Millennium", ITMO University, 9 Lomonosova Str., 191002 St. Petersburg, Russia
Interests: brain; behavior; anxiety; depression; memory; learning; schizophrenia; nutrients; nutraceuticals; vitamin D; estrogens; progesterone; DHEA; menopause; thyroid hormones; androgens; fertility; pharmacotherapy; psychology; psychoneuropharmacology; nutraceutical psychiatry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Vitamin D is an exciting topic in scientific research, especially in the last few decades. It is one of the first hormones, or even the very first one, produced on Earth. Many preclinical and clinical studies have strongly indicated that vitamin D plays several physiological and biochemical key roles in different areas of general physiology and pathophysiology. However, many questions still remain and will likely fuel ongoing investigations and debate. It is also likely that these questions will increase researchers’ interest in the different pleiotropic effects of vitamin D in the future.
This Special issue will provide a scientific perspective on vitamin D and its analogs in the mechanisms of endocrine disorders associated with gonadal hormone imbalance in men and women. This Special Issue will include both experimental/clinical articles and reviews concentrated on the most recent advances in the research into Vitamin D and its analogs used in the treatment of gonadal hormonal disorders. The major focus will be on the pleotropic action of vitamin D on the gonadal axis in both genders, with a special focus on the molecular and biochemical mechanisms of vitamin D involvement, and studies on the treatment with vitamin D and its analogs in the complex therapy of sexual hormonal disorders.
Prof. Julia O. Fedotova
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vitamin D
- estrogens
- progesterone
- DHEA
- menopause
- androgens
- fertility
- pharmacotherapy
- psychology
